7Baggers

BioNTech SE
(NASDAQ:BNTX) 

BNTX stock logo

BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is involved in the developing of FixVac product candidates, including BNT111, which is in Phase I clinical trial for advance melanoma; BNT112 that is in Phase I/IIa...

Founded: 2008
Full Time Employees: 1,800
CEO / Founder: Ugur Sahin 
Sector: Healthcare
Industry: Biotechnology
Biotechnology
Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2025-11-03 2025-09-30 2025-05-05 2024-11-04 2024-09-30 2024-08-05 2024-06-30 2024-05-06 2024-03-31 2024-03-20 2023-12-31 2023-11-06 2023-09-30 2023-08-07 2023-06-30 2023-05-08 2023-03-31 2023-03-27 2022-12-31 2022-11-07 2022-09-30 2022-06-30 2022-05-09 2022-03-31 2022-03-29 2021-11-05 2021-08-09 2021-05-10 2021-03-30 2020-12-31 2020-11-10 2020-11-09 2020-08-11 2020-05-12 2020-03-31 2019-12-31 2019-11-14 
                                         
      revenues
    		1,518,900,000 1,518,900,000 182,800,000 1,244,800,000 1,244,800,000 128,700,000 128,700,000 187,600,000 187,600,000                             
      cost of sales
    		-148,300,000 -148,300,000 -83,800,000 -178,900,000 -178,900,000 -59,800,000 -59,800,000 -59,100,000 -59,100,000 -179,100,000 -179,100,000 -161,800,000 1,400,000 -162,900,000 -162,900,000 -96,000,000 -96,000,000 -183,500,000 -702,875,000 -752,800,000 -752,800,000 -764,600,000 -1,294,100,000 -1,294,100,000 -583,200,000 -1,211,400,000 -883,800,000 -233,100,000 -59,333,000 -40,989,000 -6,840,000  -5,662,000 -5,842,000 -17,361,000 -4,436,000 -4,230,000 
      research and development expenses
    		-564,800,000 -564,800,000 -525,600,000 -550,300,000 -550,300,000 -584,600,000 -584,600,000 -507,500,000 -507,500,000 -577,800,000 -577,800,000 -497,900,000 7,700,000 -373,400,000 -373,400,000 -334,000,000 -334,000,000 -509,800,000 -256,800,000 -341,800,000 -341,800,000 -399,600,000 -285,800,000 -285,800,000 -271,500,000 -260,400,000 -201,100,000 -216,200,000 -645,029,000 -257,012,000 -227,706,000  -95,189,000 -65,122,000 -226,466,000 -65,427,000 -50,396,000 
      sales and marketing expenses
    		-27,300,000 -27,300,000 -13,700,000 -18,100,000 -18,100,000 -12,900,000 -12,900,000 -15,600,000 -15,600,000 -18,000,000 -18,000,000 -14,400,000 200,000 -18,100,000 -18,100,000 -12,200,000 -12,200,000 -14,600,000 -11,225,000 -12,800,000 -12,800,000 -17,800,000 -14,300,000 -14,300,000 -17,900,000 -10,500,000 -13,300,000 -8,700,000 -14,512,000 -6,704,000 -4,268,000  -3,054,000 -486,000 -2,718,000 -810,000 -670,000 
      general and administrative expenses
    		-121,200,000 -121,200,000 -106,900,000 -132,400,000 -132,400,000 -170,900,000 -170,900,000 -117,000,000 -117,000,000 -124,300,000 -108,400,000 -144,500,000 6,200,000 -122,700,000 -122,700,000 -119,400,000 -119,400,000 -122,900,000 -90,450,000 -141,000,000 -141,000,000 -130,000,000 -90,800,000 -90,800,000 -130,900,000 -68,200,000 -47,800,000 -38,900,000 -94,049,000 -36,097,000 -23,324,000  -18,813,000 -15,815,000 -45,547,000 -11,066,000 -10,582,000 
      other operating expenses
    		-729,500,000 -729,500,000 -48,500,000 -410,900,000 -410,900,000 -290,800,000 -290,800,000 -23,900,000 -23,900,000 -57,600,000 -69,300,000 -31,400,000  -74,200,000 -74,200,000 -118,100,000 -118,100,000 -376,200,000 -148,650,000 -285,100,000 -285,100,000 -240,700,000 -71,600,000 -71,600,000 -67,100,000 -26,400,000 -300,000  -2,358,000 -1,033,000 -466,000  -759,000 -100,000 -739,000 -576,000  
      other operating income
    		25,300,000 25,300,000 61,600,000 56,300,000 56,300,000 24,100,000 24,100,000 28,300,000 28,300,000 4,000,000 -200,000 27,800,000  20,300,000 20,300,000 57,100,000 57,100,000 221,600,000 -342,200,000 459,800,000 459,800,000 565,800,000 134,700,000 134,700,000 237,800,000 213,100,000 36,200,000  250,539,000 240,577,000 8,764,000  773,000 425,000 2,724,000 1,384,000 347,000 
      operating profit /
    		-46,900,000 -46,900,000  10,500,000 10,500,000                                 
      finance income
    		96,800,000 96,800,000 122,600,000 156,200,000 156,200,000 167,700,000 167,700,000 180,100,000 180,100,000 162,200,000 156,400,000 156,300,000  152,400,000 152,400,000 82,300,000 82,300,000 38,800,000 -118,200,000 60,900,000 60,900,000 115,500,000 272,100,000 272,100,000 31,900,000 26,600,000 300,000       6,417,000 4,122,000 -5,048,000 7,294,000 
      finance expenses
    		-25,200,000 -25,200,000 -33,900,000 -8,000,000 -8,000,000 -7,300,000 -7,300,000 -4,700,000 -4,700,000 -25,200,000 -19,400,000 -2,000,000  -1,300,000 -1,300,000 -29,000,000 -29,000,000 -159,100,000 -4,200,000 -4,300,000 -4,300,000 -5,800,000 -6,700,000 -6,700,000 -17,700,000 -81,900,000 -175,400,000       -103,000 -326,000 -93,000 -82,000 
      profit / (loss) before tax
    		24,700,000 24,700,000  158,700,000 158,700,000 -805,800,000 -805,800,000 -331,800,000 -331,800,000     -412,200,000 -412,200,000                       
      income taxes
    		-53,400,000 -53,400,000 29,600,000 39,400,000 39,400,000 -2,000,000 -2,000,000 16,700,000 16,700,000 -205,300,000 -205,300,000 -66,800,000  221,800,000 221,800,000 -205,500,000 -205,500,000 -893,900,000 -656,450,000 -659,200,000 -659,200,000 -647,300,000 -1,319,300,000 -1,319,300,000 -1,547,700,000 -1,456,400,000 -1,235,600,000 -514,200,000 161,000,000 161,293,000 -2,491,000  2,206,000  268,000 296,000  
      net profit /
    		-28,700,000 -28,700,000  198,100,000 198,100,000                                 
      earnings / (loss) per share
    		                                     
      basic earnings / (loss) per share
    		-0.12 -0.12  0.82 0.82                                 
      diluted earnings / (loss) per share
    		-0.12 -0.12  0.81 0.81                                 
      operating income
    		  -534,100,000       526,200,000 526,200,000 73,100,000    654,400,000 654,400,000                     
      yoy
    		           -88.83%                          
      qoq
    		         0.00% 619.84%     0.00%                      
      operating margin %
    		NaN% NaN% -Infinity% NaN% NaN% NaN% NaN% NaN% NaN% 35.58% 35.58% 8.16% NaN% 0% 0% 51.25% 51.25% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% 0% 0% 0% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% 
      income before tax
    		  -445,400,000                                   
      net income
    		  -415,800,000                                   
      yoy
    		                                     
      qoq
    		                                     
      net income margin %
    		NaN% NaN% -Infinity% NaN% NaN% NaN% NaN% NaN% NaN% 0% 0% 0% NaN% 0% 0% 0% 0% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% 0% 0% 0% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% 
      loss per share
    		                                     
      basic and diluted loss per share
    		  -1.73                                   
      operating income /
    		     -966,200,000 -966,200,000 -507,200,000 -507,200,000     -563,300,000 -563,300,000                       
      profit / (loss) for the period
    		     -807,800,000 -807,800,000 -315,100,000 -315,100,000     -190,400,000 -190,400,000                       
      basic earnings / (loss) for the period per share
    		     -3.36 -3.36 -1.31 -1.31                             
      diluted earnings / (loss) for the period per share
    		     -3.36 -3.36 -1.31 -1.31                             
      commercial revenues
    		         1,478,900,000 1,478,900,000 893,700,000  166,400,000 166,400,000 1,276,500,000 1,276,500,000      6,362,200,000 6,362,200,000 5,525,900,000 6,040,100,000 5,280,500,000 2,027,500,000 303,476,000         
      research & development revenues
    		         100,000 100,000 1,600,000  1,300,000 1,300,000 5,000,000 500,000 7,000,000 7,000,000 66,400,000 66,400,000 30,200,000 12,400,000  6,600,000             
      total revenues
    		         1,479,000,000 1,479,000,000 895,300,000  167,700,000 167,700,000 1,277,000,000 1,277,000,000          5,308,500,000 2,048,400,000 482,325,000         
      yoy
    		         781.93% 781.93% -29.89%                          
      qoq
    		         0.00% 65.20%   0.00% -86.87% 0.00%           159.15% 324.69%          
      profit before tax
    		         663,200,000 663,200,000 227,400,000    707,700,000 707,700,000                     
      profit for the period
    		         457,900,000 457,900,000 160,600,000    502,200,000 502,200,000                     
      earnings per share
    		                                     
      basic earnings for the period per share
    		         1.91 1.91 0.67                          
      diluted earnings for the period per share
    		         1.9 1.89 0.67                          
      expense arising from equity-settled share-based payment arrangements
    		            10,700,000                         
      employee stock ownership plan
    		            -100,000                         
      chief executive officer grant
    		            400,000                         
      management board grant
    		            1,200,000                         
      biontech 2020 employee equity plan for employees based outside north america
    		            9,200,000                         
      expense / (income) arising from cash-settled share-based payment arrangements
    		            4,800,000                         
      biontech restricted stock unit plan for north america employees
    		            3,800,000                         
      total
    		            15,500,000                         
      recognized in:
    		                                     
      basic profit / (loss) for the period per share
    		             -0.79 -0.79                       
      diluted profit / (loss) for the period per share
    		             -0.79 -0.79                       
      basic profit for the period per share
    		               2.07 2.07                     
      diluted profit for the period per share
    		               2.05 2.05                     
      attributable to:
    		                                     
      equity holders of the parent
    		                        3,166,200,000    15,198,000 366,912,000 -210,032,000  -88,296,000 -53,386,000 -179,056,000 -58,223,000 -30,103,000 
      non-controlling interests
    		                                  -116,000   
      interest expenses related to lease liabilities
    		                         -800,000 -500,000 -700,000 -2,003,000         
      other operating expenses*
    		                           -600,000          
      other operating income*
    		                           111,300,000          
      finance income**
    		                           24,800,000          
      finance expenses**
    		                           -44,000,000          
      finance income*
    		                            1,564,000 497,000 474,000  205,000     
      finance expenses*
    		                            -62,946,000 -38,491,000 -21,081,000  -9,300,000     
      share of loss of equity method investees
    		                                     
      basic and diluted, profit / (loss) for the period attributable to ordinary equity holders of the parent**
    		                                     
      revenues from contracts with customers
    		                                     
      gross profit
    		                                     
      yoy
    		                                     
      qoq
    		                                     
      gross margin %
    		NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% 0% 0% 0% NaN% 0% 0% 0% 0% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% 0% 0% 0% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% 
      interest expense related to lease liability
    		                             -358,000 -552,000  -465,000 -415,000 -1,718,000 -435,000 -433,000 
      loss before tax
    		                                     
      loss for the period
    		                                     
      in eur
    		                                     
      basic & diluted, loss per share for the period attributable to equity holders of the parent**
    		                                     
      basic & diluted, loss per share for the period attributable to ordinary equity holders of the parent*
    		                                     
      * numbers of shares for calculating the earnings per share for the three months ended march 31, 2019 have been adjusted to reflect capital increase due to 1:18 share split which occurred on september 18, 2019.
    		                                     
      basic & diluted, loss per share for the year attributable to ordinary equity holders of the parent
    		                                     
      basic & diluted, loss for the year attributable to ordinary equity holders of the parent
    		                                     
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2025-11-03 2023-05-08 2023-03-27 2022-12-31 2022-11-07 2022-09-30 2022-06-30 2022-05-09 2022-03-31 2022-03-29 2021-11-05 2021-08-09 2021-05-10 2020-12-31 2020-11-10 2020-05-12 2020-03-31 2019-12-31 2019-11-14 
                         
        assets
      		                   
        non-current assets
      		                   
        goodwill
      		357,700,000                   
        other intangible assets
      		1,389,800,000                   
        property, plant and equipment
      		1,039,700,000 639,200,000 609,200,000 609,200,000 488,500,000 488,500,000 420,400,000 358,300,000 358,300,000 322,500,000 294,400,000 261,600,000 242,400,000 226,968,000 127,739,000 96,290,000 93,044,000 93,044,000 142,631,000 
        right-of-use assets
      		201,000,000 208,400,000 211,900,000 211,900,000 272,000,000 272,000,000 243,700,000 198,600,000 198,600,000 197,900,000 147,700,000 119,500,000 118,400,000 98,988,000 55,764,000 49,131,000 55,018,000 55,018,000  
        contract assets
      		3,900,000 5,700,000              1,191,000    
        other financial assets
      		2,476,000,000 516,800,000 80,200,000 80,200,000 52,800,000 52,800,000 51,500,000 48,400,000 48,400,000 21,300,000 1,800,000 800,000 500,000 137,234,000 17,843,000 1,723,000 1,680,000 1,680,000 356,000 
        other non-financial assets
      		24,600,000 4,400,000 6,500,000 6,500,000                
        deferred tax assets
      		17,700,000 245,500,000 229,600,000 229,600,000 343,700,000 343,700,000     75,300,000 163,200,000 141,700,000 161,233,000      
        total non-current assets
      		5,510,400,000 1,992,900,000                  
        current assets
      		                   
        inventories
      		225,700,000 424,100,000 439,600,000 439,600,000 294,800,000 294,800,000 367,700,000 459,300,000 459,300,000 502,500,000 393,400,000 305,400,000 146,900,000 64,120,000 12,368,000 9,629,000 11,722,000 11,722,000 10,869,000 
        trade and other receivables
      		690,800,000 6,450,500,000 7,145,600,000 7,145,600,000 7,309,400,000 7,309,400,000 10,382,900,000 12,695,800,000 12,695,800,000 12,381,700,000 10,603,900,000 7,051,700,000 2,395,100,000       
        income tax assets
      		84,800,000 532,600,000 400,000 400,000 400,000 400,000 400,000 400,000 400,000 400,000 900,000 900,000 900,000 898,000 724,000 980,000 756,000 756,000 546,000 
        cash and cash equivalents
      		10,092,900,000 12,143,900,000 13,875,100,000 13,875,100,000 13,423,700,000 13,423,700,000 9,334,800,000 6,164,100,000 6,164,100,000 1,692,700,000 2,392,700,000 914,100,000 891,500,000 1,210,209,000 990,461,000 451,597,000 519,149,000 519,149,000 463,308,000 
        total current assets
      		15,830,700,000 20,086,100,000                  
        total assets
      		21,341,100,000 22,079,000,000                  
        equity and liabilities
      		                   
        equity
      		                   
        share capital
      		248,600,000 248,600,000 248,600,000 248,600,000 248,600,000 248,600,000 248,600,000 246,800,000 246,800,000 246,300,000 246,300,000 246,300,000 246,300,000 246,310,000 246,310,000 232,304,000   221,787,000 
        capital reserve
      		1,453,200,000 1,547,900,000 1,828,200,000 1,828,200,000 1,050,400,000 1,050,400,000 1,689,800,000 1,976,300,000 1,976,300,000 1,674,400,000 1,674,400,000 1,674,400,000 1,514,500,000 1,514,451,000 1,441,631,000 686,714,000   569,751,000 
        treasury shares
      		-8,100,000 -7,600,000 -5,300,000 -5,300,000 -10,300,000 -10,300,000 -5,900,000 -3,800,000 -3,800,000 -3,800,000 -3,800,000 -3,800,000 -4,800,000 -4,789,000 -5,525,000 -5,525,000   -5,525,000 
        retained earnings
      		18,266,900,000 19,335,200,000 18,833,000,000 18,833,000,000 16,554,300,000 16,554,300,000 14,769,400,000 13,581,700,000 13,581,700,000           
        other reserves
      		-1,483,300,000 -858,800,000 -848,900,000 -848,900,000 523,300,000 523,300,000 128,800,000 109,700,000 109,700,000 93,900,000 77,900,000 60,200,000 45,100,000 25,503,000 21,808,000 12,850,000 4,826,000 4,826,000 -3,004,000 
        total equity
      		18,477,300,000 20,265,300,000                  
        non-current liabilities
      		                   
        lease liabilities, loans and borrowings
      		192,000,000 172,400,000 176,200,000 176,200,000                
        other financial liabilities
      		96,400,000 6,100,000 6,100,000 6,100,000 6,100,000 6,100,000 6,100,000 6,100,000 6,100,000 6,100,000 324,900,000 243,400,000 73,000,000 31,476,000 132,157,000 14,030,000 13,836,000 13,836,000 15,730,000 
        provisions
      		24,200,000 8,600,000 8,600,000 8,600,000 7,300,000 7,300,000 7,300,000 240,000,000 240,000,000 184,900,000 5,700,000 5,600,000 5,600,000 5,498,000 817,000 957,000 762,000 762,000 851,000 
        contract liabilities
      		219,000,000 45,600,000 48,400,000 48,400,000 53,800,000 53,800,000 55,900,000 66,400,000 66,400,000 9,000,000 10,500,000 6,100,000 57,800,000 71,892,000 76,773,000 75,187,000 97,109,000 97,109,000 126,067,000 
        other non-financial liabilities
      		85,500,000 14,000,000 17,000,000 17,000,000                
        deferred tax liabilities
      		24,200,000 5,300,000 6,200,000 6,200,000 7,000,000 7,000,000 100,400,000 50,900,000 50,900,000 66,700,000    281,000      
        total non-current liabilities
      		641,300,000 262,800,000                  
        current liabilities
      		                   
        trade payables and other payables
      		399,800,000                   
        income tax liabilities
      		6,300,000 10,800,000 10,400,000 10,400,000 8,000,000 8,000,000 6,800,000 4,400,000 4,400,000 4,400,000 3,118,400,000         
        total current liabilities
      		2,222,500,000 1,550,900,000                  
        total liabilities
      		2,863,800,000 1,813,700,000                  
        total equity and liabilities
      		21,341,100,000 22,079,000,000                  
        intangible assets
      		 378,600,000                  
        trade payables
      		 29,900,000 204,100,000 204,100,000 296,500,000 296,500,000 291,100,000 123,700,000 123,700,000 160,000,000 258,900,000 262,700,000 106,200,000 102,288,000 41,912,000 19,417,000 20,498,000 20,498,000 21,813,000 
        refund liabilities
      		 80,200,000 24,400,000 24,400,000    90,000,000 90,000,000 90,000,000          
        other assets
      		    1,100,000 1,100,000 900,000 800,000 800,000 800,000 900,000 900,000 1,000,000 1,045,000 5,177,000 9,263,000 9,069,000 9,069,000 9,345,000 
        deferred expenses
      		    7,500,000 7,500,000 9,400,000 11,400,000 11,400,000 13,600,000 49,400,000 53,500,000 31,500,000 28,001,000      
        loans and borrowings
      		    237,000,000 237,000,000 206,600,000 155,400,000 155,400,000 171,600,000          
        other liabilities
      		    17,400,000 17,400,000 17,900,000 11,200,000 11,200,000 12,800,000 9,700,000 4,700,000 1,000,000 566,000 695,000 207,000 7,490,000 7,490,000 6,847,000 
        government grants
      		    3,000,000 3,000,000 3,000,000 3,000,000 3,000,000 3,000,000 3,100,000 3,100,000 3,200,000 91,951,000      
        retained earnings /
      		         9,882,900,000 6,716,700,000 3,505,700,000 718,500,000       
        interest-bearing loans and borrowings
      		          267,700,000 242,900,000 236,600,000 231,047,000      
        tax provisions
      		           1,750,600,000 494,900,000 11,000 150,000 150,000 150,000 150,000 297,000 
        other provisions
      		           98,000,000 900,000 903,000      
        trade receivables
      		             165,468,000 7,170,000 10,310,000 11,913,000 11,913,000 8,931,000 
        accumulated losses
      		             -409,629,000 -776,541,000 -478,213,000 -424,827,000 -424,827,000 -366,604,000 
        deferred expense
      		              9,127,000 8,162,000 5,862,000 5,862,000 7,940,000 
        financial liabilities
      		              175,621,000 66,641,000 68,904,000 68,904,000 67,813,000 
        share capital*
      		                232,304,000 232,304,000  
        capital reserve*
      		                686,714,000 686,714,000  
        treasury shares*
      		                -5,525,000 -5,525,000  
        equity attributable to equity holders of the parent
      		                   
        non-controlling interest
      		                   
        * numbers have been adjusted to reflect capital increase due to 1:18 share split which occurred on september 18, 2019.
      		                   
        non-controllng interest
      		                   
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2025-03-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-05-08 2023-03-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-05-10 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-05-12 2020-03-31 2019-12-31 
                               
          assets
        		                       
          non-current assets
        		                       
          goodwill
        		                       
          other intangible assets
        		                       
          property, plant and equipment
        		       639,200,000                
          right-of-use assets
        		       208,400,000                
          contract assets
        		       5,700,000                
          other financial assets
        		       516,800,000                
          other non-financial assets
        		       4,400,000                
          deferred tax assets
        		       245,500,000                
          total non-current assets
        		       1,992,900,000                
          current assets
        		                       
          inventories
        		       424,100,000                
          trade and other receivables
        		       6,450,500,000                
          income tax assets
        		       532,600,000                
          cash and cash equivalents
        		       12,143,900,000                
          total current assets
        		       20,086,100,000                
          total assets
        		       22,079,000,000                
          equity and liabilities
        		                       
          equity
        		                       
          share capital
        		       248,600,000                
          capital reserve
        		       1,547,900,000                
          treasury shares
        		       -7,600,000                
          retained earnings
        		       19,335,200,000                
          other reserves
        		       -858,800,000                
          total equity
        		       20,265,300,000                
          non-current liabilities
        		                       
          lease liabilities, loans and borrowings
        		       172,400,000                
          other financial liabilities
        		       6,100,000                
          provisions
        		       8,600,000                
          contract liabilities
        		       45,600,000                
          other non-financial liabilities
        		       14,000,000                
          deferred tax liabilities
        		       5,300,000                
          total non-current liabilities
        		       262,800,000                
          current liabilities
        		                       
          trade payables and other payables
        		                       
          income tax liabilities
        		       10,800,000                
          total current liabilities
        		       1,550,900,000                
          total liabilities
        		       1,813,700,000                
          total equity and liabilities
        		       22,079,000,000                
          operating activities
        		                       
          net profit
        		                       
          income taxes
        		-29,600,000 -41,400,000 18,700,000 -16,700,000 189,000,000 288,600,000 -1,541,100,000 1,319,300,000 205,500,000 11,900,000 -672,000,000 1,319,300,000 91,300,000   -514,200,000 514,200,000 -161,293,000 2,491,000 -2,206,000 8,000 8,000 -296,000 
          profit before tax
        		    958,700,000   5,018,100,000 707,700,000               
          adjustments to reconcile loss before tax to net cash flows:
        		                       
          depreciation, amortization and impairment of property, plant, equipment, intangible assets and right-of-use assets
        		                       
          share-based payment expenses
        		22,100,000 20,700,000 3,900,000 16,300,000 35,900,000 2,400,000 1,900,000 11,200,000 8,600,000               
          net foreign exchange differences
        		48,300,000 -22,300,000 15,500,000 -28,700,000 -277,600,000 376,600,000 -403,100,000 6,100,000 53,100,000 460,800,000 -350,700,000 6,100,000 102,200,000 -124,100,000 -38,900,000 -31,200,000 -31,200,000 41,195,000 130,000 218,000 -268,000 -268,000 240,000 
          loss on disposal of property, plant and equipment
        		    500,000 3,200,000   200,000         -121,000 636,000 18,000 62,000   
          finance income excluding foreign exchange differences
        		-122,600,000 11,500,000 7,200,000 -174,900,000 -371,100,000 -21,900,000 90,700,000 -217,300,000 -82,300,000               
          finance expense excluding foreign exchange differences
        		7,900,000 500,000 100,000 4,700,000 5,900,000 700,000 -5,400,000 6,700,000 1,200,000               
          government grants
        		-14,500,000 -11,500,000 6,000,000 -9,100,000                    
          other non-cash loss
        		                       
          unrealized loss on derivative instruments at fair value through profit or loss
        		                       
          working capital adjustments:
        		                       
          decrease in trade and other receivables, contract assets and other assets
        		520,700,000  1,101,400,000 498,200,000  -4,492,400,000    -929,400,000              
          decrease in inventories
        		33,800,000   12,300,000    43,200,000 15,500,000 -18,700,000 48,400,000 43,200,000    -82,800,000     2,231,000   
          increase in trade payables, other financial liabilities, other liabilities, contract liabilities, refund liabilities and provisions
        		         1,229,000,000 -1,520,600,000 857,500,000            
          interest received and realized gains from cash and cash equivalents
        		118,600,000 -7,700,000 -118,600,000 199,400,000                    
          interest paid and realized losses from cash and cash equivalents
        		-3,100,000 0 2,100,000 -3,700,000                    
          income tax received
        		                       
          share-based payments
        		-3,600,000 -127,600,000 -4,400,000 -2,400,000 -762,000,000 27,100,000 -29,500,000 -1,800,000 -725,700,000               
          government grants received
        		23,200,000 27,900,000 23,600,000 9,200,000                    
          net cash flows from operating activities
        		    4,560,200,000 -3,575,500,000                  
          investing activities
        		                       
          purchase of property, plant and equipment
        		-48,900,000 15,800,000 -30,100,000 -58,500,000 -196,200,000 14,000,000 -23,100,000 -44,100,000 -45,200,000 -7,300,000 -26,500,000 -44,100,000 1,200,000 -14,600,000 -4,200,000 -21,700,000 -21,700,000 -25,369,000 -19,268,000 -15,101,000 -6,295,000 -6,295,000 -9,971,000 
          proceeds from sale of property, plant and equipment
        		500,000 100,000   100,000        1,800,000 -100,000 -600,000 900,000 900,000 1,233,000 6,000    -547,000 
          purchase of intangible assets
        		                       
          acquisition of subsidiaries and businesses, net of cash acquired
        		-78,500,000    0             -61,534,000 0 7,407,000 -6,516,000 -6,516,000 0 
          investment in other financial assets
        		-2,507,700,000 -510,000,000 2,446,900,000 -4,895,100,000 -6,384,300,000 1,238,400,000 -1,955,500,000 -27,000,000 -680,600,000               
          proceeds from maturity of other financial assets
        		4,450,600,000 550,900,000 -379,700,000 2,727,600,000    375,200,000    375,200,000            
          net cash flows from investing activities
        		                       
          financing activities
        		                       
          repayment of loans and borrowings
        		-4,500,000    0   -18,800,000    -18,800,000 -50,200,000 200,000 0 -700,000 -700,000 -662,000 -585,000     
          payments related to lease liabilities
        		-9,300,000 12,700,000 -12,800,000 -7,800,000 -31,000,000 100,000 2,000,000 -11,400,000 -9,300,000 500,000 900,000 -11,400,000 6,600,000 2,500,000 -3,500,000 -3,800,000 -3,800,000 -9,555,000 -1,015,000 -1,284,000 -889,000 -889,000  
          net cash flows from financing activities
        		                       
          net increase in cash and cash equivalents
        		         983,000,000 -1,358,700,000 4,417,900,000            
          change in cash and cash equivalents resulting from exchange rate differences
        		-16,100,000 1,000,000 -10,100,000 6,800,000   -443,800,000 535,000,000 -27,100,000 -64,800,000 58,000,000 53,500,000 -8,800,000 24,400,000 -25,600,000 25,400,000 25,400,000       
          change in cash and cash equivalents resulting from other valuation effects
        		-13,200,000 -1,400,000 104,900,000 -64,400,000                    
          cash and cash equivalents at the beginning of the period
        		9,761,900,000 1,400,100,000 -2,687,100,000 11,663,700,000   12,142,207,300 1,692,700 13,875,100,000 3,170,700,000 4,471,400,000 1,692,700,000 1,478,600,000 22,600,000          
          cash and cash equivalents as of september 30
        		                       
          net profit /
        		                       
          profit / (loss) before tax
        		 964,500,000 -474,000,000 -331,800,000                    
          adjustments to reconcile income before tax to net cash flows:
        		                       
          (gain) / loss on disposal of property, plant and equipment
        		-100,000                       
          other non-cash (income) / loss
        		-14,300,000                       
          unrealized (gain) / loss on derivative instruments at fair value through profit or loss
        		-11,300,000                       
          decrease / (increase) in trade and other receivables, contract assets and other assets
        		       -403,500,000 893,800,000               
          (decrease) / increase in trade payables, other financial liabilities, other liabilities, contract liabilities, refund liabilities and provisions
        		 -642,900,000    -617,700,000 -264,800,000 857,500,000 -861,600,000               
          income tax received / (paid)
        		 -64,800,000           -3,456,200,000           
          net cash flows from / (used in) operating activities
        		       4,050,200,000 -677,400,000               
          net cash flows from / (used in) investing activities
        		1,246,800,000     1,059,600,000 -2,579,200,000 287,400,000 -735,400,000               
          net cash flows used in financing activities
        		-13,800,000 15,000,000 -15,100,000 -7,800,000  -147,600,000                  
          net increase / (decrease) in cash and cash equivalents
        		452,300,000    -1,629,700,000   4,417,900 -1,704,100,000               
          net income
        		-415,800,000                       
          income before tax
        		-445,400,000                       
          adjustments to reconcile profit before tax to net cash flows:
        		                       
          depreciation and amortization of property, plant, equipment, intangible assets and right-of-use assets
        		42,800,000 -5,500,000 11,600,000 38,300,000 142,100,000 9,400,000 4,300,000 27,600,000 31,400,000 300,000 5,600,000 27,600,000            
          decrease in trade payables, other financial liabilities, other liabilities, contract liabilities, refund liabilities and provisions
        		-971,000,000   -288,000,000                    
          income tax paid
        		-12,200,000   -258,800,000 -472,700,000 427,100,000 852,700,000 -1,290,000,000 -844,900,000 38,100,000 498,600,000 -1,290,000,000   -100,000 -100,000 -100,000   -144,000 -231,000 -231,000  
          net cash flows used in operating activities
        		-780,700,000   -317,300,000                    
          purchase of intangible assets and right-of-use assets
        		-569,200,000 42,500,000 25,700,000 -78,400,000 -358,200,000 144,900,000 -225,400,000 -16,700,000 -9,600,000 100,000 11,900,000 -16,700,000            
          cash and cash equivalents as of march 31
        		10,184,900,000   8,976,600,000    6,164,100 12,143,900,000               
          net cash flows used in investing activities
        		 99,300,000 2,063,000,000 -2,304,400,000                    
          proceeds from loans and borrowings
        		    200,000     200,000        53,630,000 99,498,000 0 2,899,000 2,899,000 2,933,000 
          share repurchase program
        		    -436,800,000 -147,700,000   -282,000,000 -356,900,000              
          net decrease in cash and cash equivalents
        		   -2,629,500,000            -344,100,000 -344,100,000       
          profit / (loss) for the period
        		  -492,700,000 -315,100,000                    
          decrease / (increase) in inventories
        		                -82,800,000       
          cash and cash equivalents as of june 30
        		                       
          net gain on derivative instruments at fair value through profit or loss
        		   1,700,000                    
          profit for the period
        		    769,700,000   3,698,800,000 502,200,000               
          movements in government grants
        		        -3,000,000    41,400,000 100,000 47,000,000 -67,900,000 -67,900,000 100,451,000      
          other non-cash income /
        		                       
          net (gain) / loss on derivative instruments at fair value through profit or loss
        		                       
          proceeds from issuance of share capital and treasury shares, net of costs
        		       110,500,000    110,500,000            
          dividends
        		                       
          net cash flows from / (used in) financing activities
        		       80,300,000 -291,300,000               
          cash and cash equivalents as of december 31
        		                       
          unrealized net (gain) / loss on derivative instruments at fair value through profit or loss
        		       -1,900,000 76,200,000               
          interest received
        		     27,800,000 41,800,000 700,000 53,600,000 2,800,000 800,000 700,000 -200,000 100,000 0 300,000 300,000 660,000 208,000 253,000 323,000 323,000 154,000 
          interest paid
        		     100,000 5,100,000 -6,400,000 -1,200,000 1,500,000 600,000 -6,400,000 -3,900,000 -100,000 -300,000 -1,800,000 -1,800,000 -1,985,000 -658,000 -514,000 -471,000 -471,000 -527,000 
          net income on derivative instruments at fair value through profit or loss
        		                       
          intangible assets
        		       378,600,000                
          trade payables
        		       29,900,000                
          refund liabilities
        		       80,200,000                
          other non-cash income
        		            -27,100,000     1,900,000 0     
          unrealized net loss on derivative instruments at fair value through profit or loss
        		                       
          purchase of financial instruments
        		         1,900,000              
          (investment) / proceeds from maturity of other financial assets
        		                       
          cash and cash equivalents at december 31
        		                       
          other assets
        		                       
          deferred expenses
        		                       
          loans and borrowings
        		                       
          other liabilities
        		                       
          share-based payment expense
        		         47,100,000 3,200,000 9,400,000 -5,000,000 1,100,000 4,700,000 17,300,000 17,300,000 7,994,000 7,885,000 8,113,000 8,150,000 8,150,000 7,750,000 
          finance income
        		         -6,200,000 215,800,000 -217,300,000 300,000 -300,000 0 -300,000 -300,000 -496,000 -475,000 -205,000 -388,000 -388,000 -680,000 
          finance expense
        		         -1,500,000 -900,000 6,700,000 -79,700,000 -93,200,000 131,100,000 44,000,000 44,000,000 13,061,000 7,067,000 105,000 103,000 103,000 93,000 
          net loss on derivative instruments at fair value through profit or loss
        		         -88,800,000 88,400,000 -1,900,000            
          cash and cash equivalents at september 30
        		                       
          gain on disposal of property, plant and equipment
        		              0 200,000 200,000       
          cash and cash equivalents at june 30
        		                       
          increase in trade and other receivables, contract assets and other assets
        		           -403,500,000  1,307,100,000 -2,550,500,000 -2,100,500,000 -2,100,500,000       
          investment into equity instruments designated at fair value through oci
        		           -27,000,000            
          cash and cash equivalents at march 31
        		                       
          adjustments to reconcile profit / (loss) before tax to net cash flows:
        		                       
          increase in inventories
        		            -21,100,000           
          purchase of intangibles assets and right-of-use assets
        		            -13,200,000 3,400,000 3,300,000 -7,500,000 -7,500,000       
          investment into cash deposit with an original term of six months
        		                       
          depreciation and amortization of property, plant, equipment and intangible assets
        		             3,400,000 3,400,000 13,000,000 13,000,000 12,542,000 8,777,000 8,832,000 8,593,000 8,593,000 9,809,000 
          interest on lease liability
        		             300,000 -200,000 700,000 700,000 571,000 552,000 465,000 415,000 415,000 435,000 
          increase in trade payables, other financial liabilities, other liabilities, contract liabilities and provisions
        		             -232,600,000 310,000,000 255,500,000        
          proceeds from issuance of share capital, net of costs
        		                 72,885,000 532,316,000    127,480,000 
          net increase/(decrease) in cash and cash equivalents
        		                       
          revenues
        		                       
          research & development revenues
        		                       
          commercial revenues
        		               2,027,500,000        
          total revenues
        		               2,048,400,000        
          cost of sales
        		               -233,100,000        
          research and development expenses
        		               -216,200,000        
          sales and marketing expenses
        		               -8,700,000        
          general and administrative expenses
        		               -38,900,000        
          other operating expenses*
        		               -600,000        
          other operating income*
        		               111,300,000        
          operating income
        		                       
          finance income**
        		               24,800,000        
          finance expenses**
        		               -44,000,000        
          interest expenses related to lease liabilities
        		               -700,000        
          earnings per share
        		                       
          basic profit for the period per share
        		                       
          diluted profit for the period per share
        		                       
          cash and cash equivalents at january 1
        		               1,210,200,000 1,210,200,000 0 0 0 519,149,000 519,149,000  
          (decrease) / increase in trade payables, other financial liabilities, other liabilities, contract liabilities and provisions
        		                255,500,000       
          net cash flows from/(used in) financing activities
        		                       
          loss before tax
        		                       
          share of loss of an associate and a joint venture
        		                       
          decrease in trade receivable and contract assets
        		                    -2,059,000   
          increase in trade payables, other liabilities, contract liabilities and provisions
        		                       
          loss for the period
        		                       
          decrease/(increase) in trade receivable and contract assets
        		                  -45,111,000   -2,059,000  
          decrease/(increase) in inventories
        		                  -3,754,000   2,231,000  
          (decrease)/increase in trade payables, other liabilities, contract liabilities and provisions
        		                  48,140,000     
          income tax received (paid)
        		                       
          purchase of intangibles assets
        		                  -1,073,000 -2,052,000 -2,122,000 -2,122,000 449,000 
          increase in cash and cash equivalents
        		                       
          change in cash resulting from exchange rate differences
        		                  101,000 477,000 57,000 57,000 -30,000 
          increase in trade and other payables, contract liabilities and provisions
        		                    -17,768,000   
          decrease in cash and cash equivalents
        		                    -67,609,000 -67,609,000  
          (gain)/loss on disposal of property, plant and equipment
        		                     62,000  
          (decrease)/increase in trade and other payables, contract liabilities and provisions
        		                     -17,768,000  
          payment of finance lease liabilities
        		                      -846,000 
          cash and cash equivalents at beginning of period